Literature DB >> 10973943

Cdc42 stimulates RNA splicing via the S6 kinase and a novel S6 kinase target, the nuclear cap-binding complex.

K F Wilson1, W J Wu, R A Cerione.   

Abstract

Cdc42 is a low molecular weight GTP-binding protein that plays a key regulatory role in a variety of cellular activities. The importance of the coordination of different cell functions by Cdc42 is underscored by the fact that a constitutively active Cdc42 mutant induces cellular transformation. In this study, we describe a novel function for Cdc42: its ability to stimulate pre-messenger RNA splicing. This activity is dependent on cysteine 37 in the effector loop of Cdc42 but is not dependent on cell growth. A likely candidate protein for mediating the Cdc42 effects on pre-mRNA splicing is the nuclear RNA cap-binding complex (CBC), which plays a key role in an early step of cap-dependent RNA splicing. Activation of the CBC by Cdc42 can be inhibited by rapamycin. Additionally, phosphatidylinositol 3-kinase and the Cdc42 effector, pp70 S6 kinase, stimulate the RNA cap-binding activity of the CBC. S6 kinase may directly target the CBC in vivo as it can phosphorylate the 80-kDa subunit of the CBC, CBP80, at residues that are subject to a growth factor-dependent and rapamycin-sensitive phosphorylation in vivo. Together these data suggest the involvement of a Cdc42-S6 kinase pathway in the regulation of RNA splicing, mediated by an increase in capped RNA binding by the CBC, as well as raise the possibility that the effects of Cdc42 on cell growth may be due in part to its regulation of RNA processing.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10973943     DOI: 10.1074/jbc.C000482200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

Review 1.  mTOR in health and in sickness.

Authors:  Dritan Liko; Michael N Hall
Journal:  J Mol Med (Berl)       Date:  2015-09-22       Impact factor: 4.599

Review 2.  The role of mammalian target of rapamycin (mTOR) in the regulation of pancreatic β-cell mass: implications in the development of type-2 diabetes.

Authors:  Jianling Xie; Terence P Herbert
Journal:  Cell Mol Life Sci       Date:  2011-11-09       Impact factor: 9.261

3.  Perspective: The Potential Role of Essential Amino Acids and the Mechanistic Target of Rapamycin Complex 1 (mTORC1) Pathway in the Pathogenesis of Child Stunting.

Authors:  Richard D Semba; Indi Trehan; Marta Gonzalez-Freire; Klaus Kraemer; Ruin Moaddel; M Isabel Ordiz; Luigi Ferrucci; Mark J Manary
Journal:  Adv Nutr       Date:  2016-09-15       Impact factor: 8.701

Review 4.  Unloading RNAs in the cytoplasm: an "importin" task.

Authors:  Sandra Mg Dias; Richard A Cerione; Kristin F Wilson
Journal:  Nucleus       Date:  2009-12-02       Impact factor: 4.197

Review 5.  The coming-of-age of nucleocytoplasmic transport in motor neuron disease and neurodegeneration.

Authors:  Paulo A Ferreira
Journal:  Cell Mol Life Sci       Date:  2019-02-11       Impact factor: 9.261

6.  A bird's-eye view of post-translational modifications in the spliceosome and their roles in spliceosome dynamics.

Authors:  Susannah L McKay; Tracy L Johnson
Journal:  Mol Biosyst       Date:  2010-07-29

7.  Effector proteins exert an important influence on the signaling-active state of the small GTPase Cdc42.

Authors:  Matthew J Phillips; Guillermo Calero; Britton Chan; Sekar Ramachandran; Richard A Cerione
Journal:  J Biol Chem       Date:  2008-03-18       Impact factor: 5.157

8.  The molecular basis for the regulation of the cap-binding complex by the importins.

Authors:  Sandra M G Dias; Kristin F Wilson; Katherine S Rojas; Andre L B Ambrosio; Richard A Cerione
Journal:  Nat Struct Mol Biol       Date:  2009-08-09       Impact factor: 15.369

9.  mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1/eukaryotic translation initiation factor 4E.

Authors:  Diane C Fingar; Celeste J Richardson; Andrew R Tee; Lynn Cheatham; Christina Tsou; John Blenis
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

Review 10.  Rho GTPases and their roles in cancer metabolism.

Authors:  Kristin F Wilson; Jon W Erickson; Marc A Antonyak; Richard A Cerione
Journal:  Trends Mol Med       Date:  2012-12-05       Impact factor: 11.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.